Resultados de la búsqueda 991-1000 of 11257 for anti-TNF drugs
Treatment Of Metastatic Soft Tissue Sarcoma (STS) Patients (FIBROSARC USA) ... Anti-cancer activity will be assessed every 6 ... Chemotherapy drugs, such as CC-486 ...
Data will contribute to creating treatment algorithms for symptom management for upper digestive diseases and for post-operative complications and symptoms as ...
... anti-factor de crecimiento endotelial vascular ... https://patienteducation.asgct.org/gene-therapy-101/gene-therapy-basics. ... https://primaryimmune.org/ ...
Giving rituximab together with romidepsin and lenalidomide may be a better treatment for B-cell non-Hodgkin lymphoma. Testing the Addition of an Anti-cancer ...
... treatment (including surgery, radiation and/or adjuvant or neoadjuvant chemotherapy). ... drugs in the iPSC-derived muscle cells. In Vivo Development of ...
In the Expansion Stage, the safety and efficacy of zanzalintinib as monotherapy and in combination therapy will be further evaluated in tumor-specific Expansion ...
... therapy; (2) if patient is already engaged in an ongoing cyclical systemic therapy, collection should be within three days prior to the end of the current ...
The PPCR will collect demographic and clinical data which many centers that deliver proton radiation therapy already collect in routine operations. Determinants ...
Testing the Addition of an Anti-cancer Drug, Selinexor, to the Usual Chemotherapy Treatment (Temozolomide) for Brain Tumors That Have Returned After Previous ...
Anti-cancer activity will be assessed every 6 weeks during therapy and every 12 weeks thereafter. A Study to See if the Depth of Tumor Invasion of Esophageal ...
Mayo Clinic no respalda compañías ni productos. Las recaudaciones de los avisos comerciales financian nuestra misión sin fines de lucro.
Consulta estos éxitos de venta y ofertas especiales en libros y boletines informativos de Mayo Clinic Press.
¿Te gustaría hacer una donación deducible de impuestos y ser parte de una investigación de vanguardia y de una atención médica que transforma la medicina?